openPR Logo
Press release

Lupus Nephritis Market Trends and Growth Factors Analysis

Lupus Nephritis Market

Lupus Nephritis Market

Lupus nephritis refers to the kidney damage caused by the disease lupus erythematosus. Lupus erythematosus is an autoimmune disease where the immune system turns against the body, affecting vital organs. Systemic lupus erythematosus affects the kidneys, joints, skin, and brain and can be fatal. While the primary cause of the disease is unknown, it is expected that factors such as viruses, infections, pollutants, and toxic chemicals, along with family history plays a role in causing the disease. The disease is more common in women compared to men.

View Report Overview -
https://www.transparencymarketresearch.com/lupus-nephritis-market.html

Kidney damage from lupus erythematosus can vary from mild to severe. In lupus nephritis, glomeruli or the filtering units are damaged. As a result, waste from the blood does not get filtered. A majority of the patients diagnosed with lupus erythematosus suffer from some kidney damage. The key symptoms of lupus nephritis are flank pain, dark urine, weight gain due to retention of extra fluid, swelling of hands, feet, eyes, and high blood pressure.

Global Lupus Nephritis Market: Overview

The growing prevalence of lupus nephritis and awareness among patients have propelled the growth of the global Lupus Nephritis Market. Rise in number of clinical trials conducted by key market players and the launch of new biologic drugs will also augment the growth of the global lupus nephritis market. However, prolonged regulatory processes regarding the approval of biologic drugs are likely to hamper the market’s growth in the near future.

To diagnose lupus nephritis, tests such as blood tests, urine tests, and imaging tests, including biopsy and ultrasound, are commonly conducted. There are five different types of lupus nephritis and the treatment depends upon the disease type. Biopsy is the only way to determine the type of lupus nephritis.

Medications used in the treatment of lupus nephritis include immunosuppressive drugs, corticosteroids, and drugs to prevent blood clots and low blood pressure. Corticosteroids are strong anti-inflammatory drugs that are prescribed to improve inflammations caused by lupus nephritis. Immunosuppressive drugs such as azathioprine, cyclophosphamide, and mycophenolate suppress the immune system activity that affects the kidneys. A newer medication, belimumab, is a monoclonal antibody and is prescribed as a biologic drug for the treatment of the disease. Antimalarial drugs are also used to help control the disease. Dialysis and kidney transplant are ultimately prescribed for patients suffering from loss of kidney function even with intake of drugs.

To obtain all-inclusive information on forecast analysis of Global Lupus Nephritis Market, Request a PDF Brochure Here -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=10856

Global Lupus Nephritis Market: Region-wise Outlook

The global lupus nephritis market has been segmented into four key regions: North America, Asia Pacific, Europe, and Rest of the World. Robust healthcare infrastructure and research and development activities in developed economies in North America and Europe have propelled the growth of the lupus nephritis market in these regions. The growing prevalence of the disease in North America has also augmented the market growth. It is estimated that about 1.5 million Americans suffer from lupus. In Asia Pacific, the market has registered significant demand with the introduction of biologics.

Global Lupus Nephritis Market: Key Players

Some of the key players in the global lupus nephritis market are Roche, Merck, Bristol-Myers Squibb, Eli Lilly, and GlaxoSmithKline. The key market players are focusing on the development of biologic drugs. Benlysta, developed by GlaxoSmithKline, is the only approved biologic drug in the global lupus nephritis market.

Contact

Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lupus Nephritis Market Trends and Growth Factors Analysis here

News-ID: 1846441 • Views: 196

More Releases from Transparency Market Research

Impact of Outbreak of COVID-19 on Medical Education Market : Global Industry Ana …
Transparency Market Research (TMR) has published a new report on the medical education market for the period of 2019–2027. According to the report, the global medical education market was valued at nearly US$ 31 Bn in 2018, and is projected to expand at a CAGR of more than 4% from 2019 to 2027. Rise in the number of medical schools and increase in cost of medical education are the
Healthcare BI Platform Market Companies Analysis, Advancement and Precise Outloo …
In an intensely competitive healthcare business intelligence (BI) platform market, large players are aggressively focused on expanding their geographical outreach, says Transparency Market Research (TMR) in a new market intelligence report. These large players are leveraging the cloud business model to provide healthcare BI solutions that can be accessed irrespective of location. Apart from this, savvy players are entering into partnerships with hospital groups and healthcare bodies to integrate healthcare BI
Substance Abuse Treatment Market News Research Report 2024
A recent report by Transparency Market Research on the substance abuse treatment market in the U.S. states that the competitive landscape is highly fragmented. This is because around 242 companies compete against one another in it. This also makes overall competition stiff. Some of the companies that have beat competition to emerge as leading players in the market are Pfizer Inc., Alkermes Plc, GlaxoSmithKline Plc., and Purdue Pharma LP. Their
Clinical Oncology Next Generation Sequencing Market is Thriving Worldwide By Siz …
Clinical Oncology Next Generation Sequencing: Introduction Next generation sequencing for tumor and germline DNA is required for oncology screening for therapeutic application. Rise in burden of cancer increases the need for early detection of the condition to carry out the generate target therapy. Companies are investing to develop technologically advanced devices/solutions for precision detection. In 2012, Oxford Nanopore had launched the GridION sequencing platform, which can sequence a human genome in 15

All 5 Releases


More Releases for Lupus

Global Systemic Lupus Erythematosus and Lupus Nephritis Drugs Market US$ 1.8 Bil …
The global systemic lupus erythematosus and lupus nephritis drugs market expected to reach US$ 1.8 billion by 2021, growing at CAGR 7.4% over the forecast period 2017-2021. Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease that is characterized by systemic chronic inflammation that can affect multiple major organ systems. A major contributor to morbidity and mortality among patients with SLE is renal involvement, known as lupus nephritis (LN). Visit The
Systemic Lupus Erythematosus and Lupus Nephritis Market - Global Drug Forecast a …
Latest industry research report on: Systemic Lupus Erythematosus and Lupus Nephritis Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Systemic lupus erythematosus (SLE) is a systemic inflammatory autoimmune disease that can affect any organ or tissue and is the prototypic autoimmune disease. As a multisystem disorder, SLE is heterogeneous in nature-no two cases of lupus are alike-and can affect multiple major organ systems in the
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Fore …
Recent research and the current scenario as well as future market potential of "PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 " globally. Summary Systemic lupus erythematosus (SLE) is a systemic inflammatory autoimmune disease that can affect any organ or tissue and is the prototypic autoimmune disease. As a multisystem disorder, SLE is heterogeneous in nature-no two cases of lupus are alike-and can affect multiple
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) …
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Global Clinical Trials Review, H2, 2014”. This report provides data on the Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chronic Cutaneous Lupus Erythematosus (CCLE)
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Fore …
"The Report PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" View Full Report : https://www.marketresearchreports.biz/reports/1045237/pharmapoint-systemic-lupus-erythematosus-and-market-research-reports Systemic lupus erythematosus (SLE) is a systemic inflammatory autoimmune
Lupus Erythematosus Market -API Insights, 2017
Summary Orbis Research Present “Lupus Erythematosus-API Insights, 2017” Description The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage